AN2 Therapeutics
ANTX
ANTX
51 hedge funds and large institutions have $418M invested in AN2 Therapeutics in 2023 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 16 increasing their positions, 10 reducing their positions, and 2 closing their positions.
Holders
51
Holders Change
+14
Holders Change %
+37.84%
% of All Funds
0.75%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
16
Increased
16
Reduced
10
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
TRCT
51
Tower Research Capital (TRC)
New York
| $1.29K | 63 | -2,982 | -98% |
|
52
UBS Group
Zurich,
Switzerland
| – | – | -41,046 | Closed |
|
|
HWA
53
Heritage Wealth Advisors
Richmond,
Virginia
| – | – | -1,060 | Closed |
|
|
CFGS
54
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|